Clinical Outcome and Toxicity Profiles of Patients with EGFR-mutation Positive Non-Small-Cell Lung Cancer

被引：0
|
作者：
Munawar, K. [1 ]
Sheikh, H. [1 ]
机构：
[1] Shaukat Khanum Mem Canc Hosp, Lahore, Pakistan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
EGFR mutation; EGFR-TKI; Lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P76.75
引用
收藏
页码：S621 / S622
页数：2
相关论文
共 50 条
  • [21] Data reported for gefitinib use in Caucasian EGFR mutation-positive non-small-cell lung cancer patients
    Lake, Francesca
    [J]. FUTURE ONCOLOGY, 2013, 9 (07) : 930 - 930
  • [22] Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer
    Kim, Jung Soo
    Cho, Min Seong
    Nam, Jong Hyeon
    Kim, Hyun-Jung
    Choi, Kyeng-Won
    Ryu, Jeong-Seon
    [J]. PLOS ONE, 2017, 12 (05):
  • [23] PROGNOSTIC IMPACT OF EGFR MUTATION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH FAMILY HISTORY OF LUNG CANCER
    Kwak, S. M.
    Soo, K. Jung
    Ryu, J. S.
    [J]. RESPIROLOGY, 2016, 21 : 111 - 111
  • [24] EGFR mutational status and clinical outcome to gefitinib monotherapy in chemonaive non-small-cell lung cancer patients
    不详
    [J]. PHARMACOGENOMICS, 2008, 9 (10) : 1382 - 1382
  • [25] Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib
    Ma, Fei
    Sun, Tong
    Shi, Yuankai
    Yu, Dianke
    Tan, Wen
    Yang, Ming
    Wu, Chen
    Chu, Datong
    Sun, Yan
    Xu, Binghe
    Lin, Dongxin
    [J]. LUNG CANCER, 2009, 66 (01) : 114 - 119
  • [26] EGFR mutation positive stage IV non-small-cell lung cancer: treatment beyond progression
    Van Assche, Katrijn
    Ferdinande, Liesbeth
    Lievens, Yolande
    Vandecasteele, Katrien
    Surmont, Veerle
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [27] EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study
    de Mello, Ramon Andrade
    Pires, Filipa Soares
    Marques, Dania Sofia
    Oliveira, Julio
    Rodrigues, Ana
    Soares, Marta
    Azevedo, Isabel
    Peixoto, Ana
    Santos, Catarina
    Pinto, Carla
    Hespanhol, Venceslau
    Teixeira, Manuel R.
    Amaro, Teresina
    Queiroga, Henrique
    Araujo, Antonio
    [J]. TUMOR BIOLOGY, 2012, 33 (06) : 2061 - 2068
  • [28] Efficacy of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Patients with/without EGFR-Mutation: Evidence Based on Recent Phase III Randomized Trials
    Zhang, Wen-Qian
    Li, Tong
    Li, Hui
    [J]. MEDICAL SCIENCE MONITOR, 2014, 20 : 2666 - 2676
  • [29] EGFR mutation and response to chemotherapy in non-small-cell lung cancer (NSCLC) patients.
    Lee, KH
    Han, SW
    Jeong, S
    Kim, DW
    Chung, DH
    Im, SA
    Kim, TY
    Heo, DS
    Bang, YJ
    Kim, NK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 641S - 641S
  • [30] Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer
    Bai, Hua
    Wang, Zhijie
    Chen, Keneng
    Zhao, Jun
    Lee, J. Jack
    Wang, Shuhang
    Zhou, Qinghua
    Zhuo, Minglei
    Mao, Li
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Liang, Zhen
    Wang, Yuyan
    Kang, Xiaozheng
    Wang, Jie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3077 - 3083
12345